An Aβ42 variant that inhibits intra- and extracellular amyloid aggregation and enhances cell viability.

Abstract excerpt

Aggregation and accumulation of the 42-residue amyloid β peptide (Aβ42) in the extracellular matrix and within neuronal cells is considered a major cause of neuronal cell cytotoxicity and death in Alzheimer's disease (AD) patients. Therefore, molecules that bind to Aβ42 and prevent its aggregation are therapeutically promising as AD treatment. Here, we show that a non-self-aggregating Aβ42 variant carrying two...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Amyloid
• Share to Amyloid beta-Peptides
• Share to Cell Survival